<VariationArchive RecordType="classified" VariationID="2428640" VariationName="NM_001042492.3(NF1):c.3850del (p.Lys1283_Ile1284insTer)" VariationType="Deletion" Accession="VCV002428640" Version="3" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-03-05" DateCreated="2023-02-13" MostRecentSubmission="2023-03-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2402082" VariationID="2428640">
      <GeneList>
        <Gene Symbol="NF1" FullName="neurofibromin 1" GeneID="4763" HGNC_ID="HGNC:7765" Source="calculated" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="31094927" stop="31377677" display_start="31094927" display_stop="31377677" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NW_025791803.1" start="174101" stop="456540" display_start="174101" display_stop="456540" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="29421944" stop="29704694" display_start="29421944" display_stop="29704694" Strand="+" />
          </Location>
          <OMIM>613113</OMIM>
          <Haploinsufficiency last_evaluated="2023-02-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NF1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-02-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NF1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001042492.3(NF1):c.3850del (p.Lys1283_Ile1284insTer)</Name>
      <CanonicalSPDI>NC_000017.11:31235748:AAAA:AAA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q11.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="31235749" stop="31235749" display_start="31235749" display_stop="31235749" variantLength="1" positionVCF="31235748" referenceAlleleVCF="TA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="29562767" stop="29562767" display_start="29562767" display_stop="29562767" variantLength="1" positionVCF="29562766" referenceAlleleVCF="TA" alternateAlleleVCF="T" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.29562770del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.29562770del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.31235752del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.31235752del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009018.1" sequenceAccession="NG_009018" sequenceVersion="1" change="g.145776del">
            <Expression>NG_009018.1:g.145776del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000267.3" sequenceAccession="NM_000267" sequenceVersion="3" change="c.3850del">
            <Expression>NM_000267.3:c.3850del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000258.1" sequenceAccession="NP_000258" sequenceVersion="1" change="p.Lys1283_Ile1284insTer">
            <Expression>NP_000258.1:p.Lys1283_Ile1284insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001042492.3" sequenceAccession="NM_001042492" sequenceVersion="3" change="c.3850del" MANESelect="true">
            <Expression>NM_001042492.3:c.3850del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001035957.1" sequenceAccession="NP_001035957" sequenceVersion="1" change="p.Lys1283_Ile1284insTer">
            <Expression>NP_001035957.1:p.Lys1283_Ile1284insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_214" sequenceAccession="LRG_214">
            <Expression>LRG_214:g.145776del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_214t1" sequenceAccession="LRG_214t1">
            <Expression>LRG_214t1:c.3850del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_214p1" sequenceAccession="LRG_214p1" change="p.Lys1283_Ile1284insTer">
            <Expression>LRG_214p1:p.Lys1283_Ile1284insTer</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_214t2" sequenceAccession="LRG_214t2">
            <Expression>LRG_214t2:c.3850del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_214p2" sequenceAccession="LRG_214p2" change="p.Ile1284Terfs">
            <Expression>LRG_214p2:p.Ile1284Terfs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001042492.3(NF1):c.3850del (p.Lys1283_Ile1284insTer) AND not provided" Accession="RCV003120241" Version="3">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="CN517202">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-09" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-03-09" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-13" MostRecentSubmission="2023-03-04">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Developmental Genetics Unit, King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="CN517202" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7080533" SubmissionDate="2023-01-06" DateLastUpdated="2023-03-04" DateCreated="2023-02-13">
        <ClinVarSubmissionID localKey="3359868|MedGen:CN235283" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003800213" DateUpdated="2023-03-04" DateCreated="2023-02-13" Type="SCV" Version="2" SubmitterName="ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories" OrgID="25969" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The NF1 c.3850delA; p.Ile1284Ter variant, also published as c.3847delA, is reported in the literature in at least one individual with NF1 and optic glioma (De Luca 2004, Melloni 2019). This variant deletes a single nucleotide, leading to an immediate early termination codon and is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Additionally, several downstream truncating variants have been described in individuals with NF1 and are considered pathogenic (De Luca 2004). Based on available information, this variant is classified as pathogenic. References: De Luca A et al. Novel and recurrent mutations in the NF1 gene in Italian patients with neurofibromatosis type 1. Hum Mutat. 2004 Jun;23(6):629. PMID: 15146469. Melloni G et al. Risk of Optic Pathway Glioma in Neurofibromatosis Type 1: No Evidence of Genotype-Phenotype Correlations in A Large Independent Cohort. Cancers (Basel). 2019 Nov 21;11(12):1838. PMID: 31766501.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ARUP Molecular Germline Variant Investigation Process 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/ythvkvge/arup_molecular_germline_variant_investigation_process_2021.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.29562770del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN235283" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2022 ARUP ClinVar submission</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7080533" TraitType="Disease" MappingType="XRef" MappingValue="CN235283" MappingRef="MedGen">
        <MedGen CUI="CN517202" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

